{
    "clinical_study": {
        "@rank": "63928", 
        "arm_group": [
            {
                "arm_group_label": "Bronchiolitis Obliterans 2 & 3", 
                "arm_group_type": "Experimental", 
                "description": "Assessment of sleep disorders and treatment if required"
            }, 
            {
                "arm_group_label": "Bronchiolitis Obliterans 0", 
                "arm_group_type": "Active Comparator", 
                "description": "Assessment of sleep disorders and treatment if required"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is to determine whether sleep disorders contribute to impaired quality of life\n      and mobility in patients with Bronchiolitis Obliterans syndrome and  whether non invasive\n      positive airways pressure  ventilation can improve sleep, quality of life and mobility in\n      this patient group."
        }, 
        "brief_title": "Sleep Disorders in BOS 2&3", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Bronchiolitis Obliterans", 
            "Sleep Disordered Breathing Central"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Bronchiolitis", 
                "Bronchiolitis Obliterans", 
                "Sleep Apnea Syndromes", 
                "Sleep Disorders", 
                "Parasomnias"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients with Bronchiolitis Obliterans syndrome (BOS) 2 & 3  (25) will be matched 1:2  BOS 0\n      patients with similar demographics such as age, gender, BMI, time post transplant and renal\n      dysfunction.Patients fitting inclusion/exclusion criteria once they have given informed\n      consent will complete questionnaires on quality of life (QOL), any sleep issues they may\n      have and be assessed by a doctor. Data from standard blood tests, respiratory function tests\n      and physio assessments of daytime activity, mobility and muscle strength will be collected.\n      All participants will undergo an overnight sleep study. If  a sleep disorder is identified\n      the participant will be offered appropriate treatment. All assessments with the exception of\n      the sleep study will be repeated at 6 and 12 months post sleep study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients who are post lung, heart lung and heart lung liver transplant with\n             bronchiolitis obliterans 2 & 3\n\n          -  Comparative group -Patients who are post lung, heart lung and heart lung liver\n             transplant with bronchiolitis obliterans 0\n\n          -  Identified possible sleep related disorder\n\n        Exclusion Criteria:\n\n          -  Subjects who do not provide informed consent\n\n          -  Subjects unable to understand the study and related procedures\n\n          -  Patients with a life expectancy of less than 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02109237", 
            "org_study_id": "HREC/13/QPCH/217"
        }, 
        "intervention": {
            "arm_group_label": [
                "Bronchiolitis Obliterans 2 & 3", 
                "Bronchiolitis Obliterans 0"
            ], 
            "description": "Assessment of sleep disorders and treatment if required", 
            "intervention_name": "Assessment of sleep disorders and treatment if required", 
            "intervention_type": "Procedure", 
            "other_name": "Level 1 polysomnograpgh assessment and treatment if required"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lung transplantation", 
            "Bronchiolitis obliterans"
        ], 
        "lastchanged_date": "April 8, 2014", 
        "location": {
            "contact": {
                "email": "andreas.fiene@health.qld.gov.au", 
                "last_name": "Andreas Fiene, BA Med, Surg FRACP MD", 
                "phone": "+61 07 31394000"
            }, 
            "contact_backup": {
                "email": "james.douglas@health.qld.gov.au", 
                "last_name": "James Douglas, MBBS FRACP MD", 
                "phone": "+61 07 3139 4000"
            }, 
            "facility": {
                "address": {
                    "city": "Brisbane", 
                    "country": "Australia", 
                    "state": "Queensland", 
                    "zip": "4032"
                }, 
                "name": "The Prince Charles Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Andreas Fiene, BA Med Surg FRACP MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "James Douglas, MBBS FRACP MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Australia"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Prevalence and Treatment of Sleep Disorders in Lung Transplant Recipients With BOS 2 & 3 and the Influence on Quality of Life and Daytime Activity.", 
        "other_outcome": [
            {
                "description": "As part of standard care transplant patients are assessed for daytime activity, mobility and muscle strength every 6months this data will be used to assess any changes post treatment for sleep disorders", 
                "measure": "Assessment of daytime activity, mobility and muscle strength", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months post sleep study"
            }, 
            {
                "description": "Assessment of lung function to determine any variation post treatment for sleep disorder.", 
                "measure": "Lung function assessment", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 and 12 months post sleep study"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "The Prince Charles Hospital", 
                "last_name": "Andreas Fiene, BA Med,Surg. FRACP MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "The Prince Charles Hospital", 
                "last_name": "James Douglas, MBBS FRACP MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Australia: Human Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using level one laboratory based polysomnograph", 
            "measure": "To Measure Prevalence of sleep disorders in Bronchiolitis Obliterans  2&3 patients", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02109237"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Prince Charles Hospital", 
            "investigator_full_name": "Philip Lee", 
            "investigator_title": "Dr A. Fiene & Dr J Douglas", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Participants will complete Rand SF36 standard survey for Quality of life. This will be completed at baseline visit and at 6 and 12 months post sleep study", 
            "measure": "Quality of life assessment using Rand SF36 standard survey", 
            "safety_issue": "Yes", 
            "time_frame": "Baseline, 6 and 12 months after sleep study"
        }, 
        "source": "The Prince Charles Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Medical Health Technologies  Australia", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "The Prince Charles Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}